col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

Elsevier: EBioMedicine
  original article Date Title Authors   All Authors
1 [GO] 2021―Jul―23 Shorter leukocyte telomere length is associated with adverse COVID-19 outcomes: A cohort study in UK Biobank Qingning Wang, Veryan Codd, Zahra Raisi-Estabragh, Crispin Musicha, Vasiliki Bountziouka, Stephen Kaptoge, et al. (+10)
2 [GO] 2021―Jul―23 SARS-CoV-2 activates lung epithelial cell proinflammatory signaling and leads to immune dysregulation in COVID-19 patients Huarong Chen, Weixin Liu, Yifei Wang, Dabin Liu, Liuyang Zhao, Jun Yu
3 [GO] 2021―Jul―23 Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France Tom Woudenberg, Stéphane Pelleau, François Anna, Mikael Attia, Françoise Donnadieu, Alain Gravet, et al. (+32)
4 [GO] 2021―Jul―17 COVID-19 rapid antigen testing strategies require careful evaluation Jacqueline Dinnes
5 [GO] 2021―Jul―10 Unleashing immuno-mass spectrometry superpowers to detect SARS-CoV-2 Jean Armengaud
6 [GO] 2021―Jul―03 Fibrotic lung disease: A molecular glimpse into severe Covid-19? Paolo Spagnolo, Justin M Oldham
7 [GO] 2021―Jul―03 A mass spectrometry-based targeted assay for detection of SARS-CoV-2 antigen from clinical specimens Santosh Renuse, Patrick M. Vanderboom, Anthony D. Maus, Jennifer V. Kemp, Kari M. Gurtner, Anil K. Madugundu, et al. (+11)
8 [GO] 2021―Jun―26 NK cells on the ViP stage of COVID-19 Elena Masselli, Marco Vitale
9 [GO] 2021―Jun―26 Corrigendum to “itraconazole for COVID-19: Preclinical studies and a proof-of-concept randomized clinical trial Laurens” Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Laure-Anne Teuwen, et al. (+33)
10 [GO] 2021―Jun―26 Clinical performance evaluation of SARS-CoV-2 rapid antigen testing in point of care usage in comparison to RT-qPCR Isabell Wagenhäuser, Kerstin Knies, Vera Rauschenberger, Michael Eisenmann, Miriam McDonogh, Nils Petri, et al. (+14)
11 [GO] 2021―Jun―20 50-gene risk profiles in peripheral blood predict COVID-19 outcomes: A retrospective, multicenter cohort study Brenda M. Juan Guardela, Jiehuan Sun, Tong Zhang, Bing Xu, Joseph Balnis, Yong Huang, et al. (+7)
12 [GO] 2021―Jun―13 Letter to the Editor re: Baldassarri et al., 2021 “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males” Soha Ghanian, Carlos G. Wambier
13 [GO] 2021―Jun―13 In response to the letter to the editor by Soha Ghanian et al. re our publication “Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males” Andrea M. Isidori, Marco Marcelli, Maria Grazia Castagna, Margherita Baldassarri, Francesca Fava, Alessandra Renieri
14 [GO] 2021―Jun―11 AI-guided discovery of the invariant host response to viral pandemics Debashis Sahoo, Gajanan D. Katkar, Soni Khandelwal, Mahdi Behroozikhah, Amanraj Claire, Vanessa Castillo, et al. (+16)
15 [GO] 2021―Jun―04 Procoagulant activity of extracellular vesicles in plasma of patients with SARS-CoV-2 infection L. Theresa
16 [GO] 2021―Jun―04 Accuracy of four lateral flow immunoassays for anti SARS-CoV-2 antibodies: a head-to-head comparative study Hayley E Jones, Ranya Mulchandani, Sian Taylor-Phillips, A E Ades, Justin Shute, Keith R Perry, et al. (+9)
17 [GO] 2021―Jun―04 SARS-CoV-2 elicits robust adaptive immune responses regardless of disease severity Stine SF Nielsen, Line K Vibholm, Ida Monrad, Rikke Olesen, Giacomo S Frattari, Marie H Pahus, et al. (+9)
18 [GO] 2021―Jun―04 SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic Matthieu Schoenhals, Niry Rabenindrina, Jean Marius Rakotondramanga, Philippe Dussart, Rindra Randremanana, Jean-Michel Heraud, et al. (+7)
19 [GO] 2021―May―26 SARS-CoV-2 vaccines for all but a single dose for COVID-19 survivors Matthew Frieman, Anthony D. Harris, Ramin Sedaghat Herati, Florian Krammer, Alberto Mantovani, Maria Rescigno, et al. (+2)
20 [GO] 2021―May―25 Biomarkers for severe COVID-19 Xin Li, Kelvin K.W. To
21 [GO] 2021―May―25 A lethal mouse model using a mouse-adapted SARS-CoV-2 strain with enhanced binding to mouse ACE2 as an important platform for COVID-19 research Hin Chu, Jasper Fuk-Woo Chan
22 [GO] 2021―May―25 Comparing infectivity and virulence of emerging SARS-CoV-2 variants in Syrian hamsters Rana Abdelnabi, Robbert Boudewijns, Caroline S. Foo, Laura Seldeslachts, Lorena Sanchez-Felipe, Xin Zhang, et al. (+7)
23 [GO] 2021―May―14 Clinical features and prognostic factors in Covid-19: A prospective cohort study Sanne de Bruin, Lieuwe D. Bos, Marian A. van Roon, Anita M. Tuip-de Boer, Alex R. Schuurman, Marleen J.A. Koel-Simmelinck, et al. (+10)
24 [GO] 2021―May―14 Q493K and Q498H substitutions in Spike promote adaptation of SARS-CoV-2 in mice Kun Huang, Yufei Zhang, Xianfeng Hui, Ya Zhao, Wenxiao Gong, Ting Wang, et al. (+11)
25 [GO] 2021―May―14 Defective NET clearance contributes to sustained FXII activation in COVID-19-associated pulmonary thrombo-inflammation Hanna Englert, Chandini Rangaswamy, Carsten Deppermann, Jan-Peter Sperhake, Christoph Krisp, Danny Schreier, et al. (+14)
26 [GO] 2021―May―13 An epigenetic signature to fight COVID-19 Georges Herbein
27 [GO] 2021―May―13 HERV-W envelope expression in blood leukocytes as a marker of disease severity of COVID-19 Marta Garcia-Montojo, Avindra Nath
28 [GO] 2021―May―09 Blood neutrophils from children with COVID-19 exhibit both inflammatory and anti-inflammatory markers Vanesa Seery, Silvina C. Raiden, Silvia C. Algieri, Nicolás A. Grisolía, Daniela Filippo, Norberto De Carli, et al. (+29)
29 [GO] 2021―May―07 Circulating extracellular vesicles are endowed with enhanced procoagulant activity in SARS-CoV-2 infection Carolina Balbi, Jacopo Burrello, Sara Bolis, Edoardo Lazzarini, Vanessa Biemmi, Enea Pianezzi, et al. (+8)
30 [GO] 2021―Apr―26 Increased viral variants in children and young adults with impaired humoral immunity and persistent SARS-CoV-2 infection: A consecutive case series Thao T. Truong, Alex Ryutov, Utsav Pandey, Rebecca Yee, Lior Goldberg, Deepa Bhojwani, et al. (+21)
31 [GO] 2021―Apr―25 The duplicitous nature of ACE2 in COVID-19 disease EBioMedicine (invited commentary) Samuel N. Heyman, Safa Kinaneh, Zaid Abassi
32 [GO] 2021―Apr―25 Research on COVID-19 therapy: Putting the cart alongside the horse Alexandre Duvignaud, Xavier Anglaret
33 [GO] 2021―Apr―25 A comprehensive antigen production and characterisation study for easy-to-implement, specific and quantitative SARS-CoV-2 serotests Miriam Klausberger, Mark Duerkop, Helmuth Haslacher, Gordana Wozniak-Knopp, Monika Cserjan-Puschmann, Thomas Perkmann, et al. (+52)
34 [GO] 2021―Apr―16 Evidence of the pathogenic HERV-W envelope expression in T lymphocytes in association with the respiratory outcome of COVID-19 patients Emanuela Balestrieri, Antonella Minutolo, Vita Petrone, Marialaura Fanelli, Marco Iannetta, Vincenzo Malagnino, et al. (+13)
35 [GO] 2021―Apr―16 Epigenome-wide association study of COVID-19 severity with respiratory failure Manuel Castro de Moura, Veronica Davalos, Laura Planas-Serra, Damiana Alvarez-Errico, Carles Arribas, Montserrat Ruiz, et al. (+26)
36 [GO] 2021―Apr―14 Corrigendum to ‘Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays’ Nuttada Panpradist, Qin Wang, Parker S. Ruth, Jack H. Kotnik, Amy K. Oreskovic, Abraham Miller, et al. (+7)
37 [GO] 2021―Apr―14 'Geno-to-pheno' SARS-CoV-2 genome-COVID-19 association studies Julian W Tang
38 [GO] 2021―Apr―14 High dimensional cytokine panels reveal common SARS-CoV-2-related inflammation patterns across different latitudes Paolo Palma
39 [GO] 2021―Apr―08 Association of SARS-CoV-2 clades with clinical, inflammatory and virologic outcomes: An observational study Barnaby E Young, Wycliffe E Wei, Siew-Wai Fong, Tze-Minn Mak, Danielle E Anderson, Yi-Hao Chan, et al. (+20)
40 [GO] 2021―Apr―02 Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India. Aishwarya Venkataraman, Nathella Pavan Kumar, Luke Elizabeth Hanna, Sulochana Putlibai, M Karthick, Anuradha Rajamanikam, et al. (+3)
41 [GO] 2021―Apr―02 The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada Aidan M. Nikiforuk, Kevin S. Kuchinski, David D.W. Twa, Christine D. Lukac, Hind Sbihi, C.Andrew Basham, et al. (+6)
42 [GO] 2021―Apr―02 Bridging animal and clinical research during SARS-CoV-2 pandemic: A new-old challenge Martin S. Winkler, Tomasz Skirecki, Frank M. Brunkhorst, Sara Cajander, Jean-Marc Cavaillon, Ricard Ferrer, et al. (+17)
43 [GO] 2021―Mar―21 Androgenicity-not serum testosterone-correlates best with COVID-19 outcome in European males Luca Giovanelli, Richard Quinton
44 [GO] 2021―Mar―21 Itraconazole for COVID-19: preclinical studies and a proof-of-concept randomized clinical trial Laurens Liesenborghs, Isabel Spriet, Dirk Jochmans, Ann Belmans, Iwein Gyselinck, Laure-Anne Teuwen, et al. (+33)
45 [GO] 2021―Mar―11 Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity João Fadista, Luke M. Kraven, Juha Karjalainen, Shea J. Andrews, Frank Geller, J Kenneth Baillie, et al. (+3)
46 [GO] 2021―Mar―08 Temporal dynamics of the host molecular responses underlying severe COVID-19 progression and disease resolution Eugenia Z Ong, Shirin Kalimuddin, Wen Chong Chia, Sarah H Ooi, Clara WT Koh, Hwee Cheng Tan, et al. (+4)
47 [GO] 2021―Mar―07 Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity Markus Hoffmann, Heike Hofmann-Winkler, Joan C. Smith, Nadine Krüger, Prerna Arora, Lambert K. Sørensen, et al. (+17)
48 [GO] 2021―Mar―02 Time series analysis and mechanistic modelling of heterogeneity and sero-reversion in antibody responses to mild SARS-CoV-2 infection Charlotte Manisty, Thomas Alexander Treibel, Melanie Jensen, Amanda Semper, George Joy, Rishi K Gupta, et al. (+22)
49 [GO] 2021―Feb―26 Shorter androgen receptor polyQ alleles protect against life-threatening COVID-19 disease in European males Margherita Baldassarri, Nicola Picchiotti, Francesca Fava, Chiara Fallerini, Elisa Benetti, Sergio Daga, et al. (+34)
50 [GO] 2021―Feb―25 COVID-19-associated surge of atopic dermatitis
51 [GO] 2021―Feb―24 Non-communicable diseases pandemic and precision medicine: Is Africa ready? Tinashe Chikowore, Abram Bunya Kamiza, Ovokeraye H. Oduaran, Tafadzwa Machipisa, Segun Fatumo
52 [GO] 2021―Feb―12 Simpler and faster Covid-19 testing: Strategies to streamline SARS-CoV-2 molecular assays Nuttada Panpradist, Qin Wang, Parker S. Ruth, Jack H. Kotnik, Amy K. Oreskovic, Abraham Miller, et al. (+7)
53 [GO] 2021―Feb―10 Persistent viral RNA shedding in COVID-19: Caution, not fear Mario Plebani
54 [GO] 2021―Feb―06 Evaluating the effects of cardiometabolic exposures on circulating proteins which may contribute to severe SARS-CoV-2 Tom G Richardson, Si Fang, Ruth E Mitchell, Michael V Holmes, George Davey Smith
55 [GO] 2021―Jan―30 SARS-CoV-2 persistence is associated with antigen-specific CD8 T-cell responses Line K Vibholm, Stine SF Nielsen, Marie H Pahus, Giacomo S Frattari, Rikke Olesen, Rebecca Andersen, et al. (+11)
56 [GO] 2021―Jan―10 Understanding the pharmacokinetics of Favipiravir: Implications for treatment of influenza and COVID-19 Michael G. Ison, Marc H. Scheetz
57 [GO] 2021―Jan―10 A breath of fresh air - the potential for COVID-19 breath diagnostics Cristina E. Davis, Michael Schivo, Nicholas J. Kenyon
58 [GO] 2021―Jan―10 SARS-CoV-2 leads to a small vessel endotheliitis in the heart Umberto Maccio, Annelies S. Zinkernagel, Srikanth Mairpady Shambat, Xiankun Zeng, Gieri Cathomas, Frank Ruschitzka, et al. (+3)
59 [GO] 2021―Jan―10 Adjuvanted SARS-CoV-2 spike protein elicits neutralizing antibodies and CD4 T cell responses after a single immunization in mice Katharina Wørzner, Daniel J. Sheward, Signe Tandrup Schmidt, Leo Hanke, Julie Zimmermann, Gerald McInerney, et al. (+4)
60 [GO] 2020―Dec―17 Reducing transmission of SARS-CoV-2 with intranasal prophylaxis Federico Boiardi, Justin Stebbing
61 [GO] 2020―Dec―09 COVID-19 reinfection: are we ready for winter?
62 [GO] 2020―Dec―04 Metabolomics of exhaled breath in critically ill COVID-19 patients: A pilot study Stanislas Grassin-Delyle, Camille Roquencourt, Pierre Moine, Gabriel Saffroy, Stanislas Carn, Nicholas Heming, et al. (+7)
63 [GO] 2020―Dec―03 Prophylactic intranasal administration of a TLR2/6 agonist reduces upper respiratory tract viral shedding in a SARS-CoV-2 challenge ferret model Pamela C. Proud, Daphne Tsitoura, Robert J. Watson, Brendon Y. Chua, Marilyn J. Aram, Kevin R. Bewley, et al. (+20)
64 [GO] 2020―Nov―21 Newcastle disease virus (NDV) expressing the spike protein of SARS-CoV-2 as a live virus vaccine candidate Weina Sun, Sarah R. Leist, Stephen McCroskery, Yonghong Liu, Stefan Slamanig, Justine Oliva, et al. (+7)
65 [GO] 2020―Nov―11 A clade of SARS-CoV-2 viruses associated with lower viral loads in patient upper airways Ramon Lorenzo-Redondo, Hannah H. Nam, Scott C. Roberts, Lacy M. Simons, Lawrence J. Jennings, Chao Qi, et al. (+5)
66 [GO] 2020―Nov―10 Corrigendum to ‘A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19 Oliver J McElvaney, Brian D Hobbs, Dandi Qiao, Oisín F McElvaney, Matthew Moll, Natalie L McEvoy, et al. (+6)
67 [GO] 2020―Nov―05 Analytical and clinical performances of five immunoassays for the detection of SARS-CoV-2 antibodies in comparison with neutralization activity Andrea Padoan, Francesco Bonfante, Matteo Pagliari, Alessio Bortolami, Davide Negrini, Silvia Zuin, et al. (+4)
68 [GO] 2020―Nov―05 SARS-CoV-2 antibody-based SURVEILLANCE: New light in the SHADOW Mario Plebani
69 [GO] 2020―Nov―04 Persistence of viral RNA, pneumocyte syncytia and thrombosis are hallmarks of advanced COVID-19 pathology Rossana Bussani, Edoardo Schneider, Lorena Zentilin, Chiara Collesi, Hashim Ali, Luca Braga, et al. (+7)
70 [GO] 2020―Nov―03 Predicting outcomes in COVID-19: From internal validation to improving care Ryeyan Taseen, André M. Cantin
71 [GO] 2020―Oct―23 COVID-19 and lombardy: TESTing the impact of the first wave of the pandemic Luca Perico, Susanna Tomasoni, Tobia Peracchi, Annalisa Perna, Anna Pezzotta, Giuseppe Remuzzi, Ariela Benigni
72 [GO] 2020―Oct―21 Blockade of an innate immune amplifier to fight immune hyperactivation in COVID-19? Alexandra K. Kiemer
73 [GO] 2020―Oct―09 A CRISPR-Cas12a-based specific enhancer for more sensitive detection of SARS-CoV-2 infection Weiren Huang, Lei Yu, Donghua Wen, Dong Wei, Yangyang Sun, Huailong Zhao, et al. (+38)
74 [GO] 2020―Oct―08 A linear prognostic score based on the ratio of interleukin-6 to interleukin-10 predicts outcomes in COVID-19 Oliver J McElvaney, Brian D Hobbs, Dandi Qiao, Oisín F McElvaney, Matthew Moll, Natalie L McEvoy, et al. (+6)
75 [GO] 2020―Oct―07 The role for the metagenome in the pathogenesis of COVID-19 Robert P Friedland, Bodduluri Haribabu
76 [GO] 2020―Oct―07 Tocilizumab is recommended for the treatment of severe COVID-19 Yonggang Zhou, Haiming Wei
77 [GO] 2020―Sep―25 Characterizing COVID-19 maternal-fetal transmission and placental infection using comprehensive molecular pathology David A. Schwartz, Kristen M. Thomas
78 [GO] 2020―Sep―24 Differential expression of ACE2 in the respiratory tracts and its relationship to COVID-19 pathogenesis Chunxiu Yang, Yueying Li, Shu-Yuan Xiao
79 [GO] 2020―Sep―22 Positive, again! What to make of “re-positive” SARS-CoV-2 molecular test results Viviana Simon, Harm van Bakel, Emilia Mia Sordillo
80 [GO] 2020―Sep―16 Impact of interleukin-6 blockade with tocilizumab on SARS-CoV-2 viral kinetics and antibody responses in patients with COVID-19: A prospective cohort study Mar Masiá, Marta Fernández-González, Sergio Padilla, Piedad Ortega, José A. García, Vanesa Agulló, et al. (+4)
81 [GO] 2020―Aug―30 Monocyte activation in systemic Covid-19 infection: Assay and rationale Fernando O. Martinez, Theo W. Combes, Federica Orsenigo, Siamon Gordon
82 [GO] 2020―Aug―25 Beneficial non-anticoagulant mechanisms underlying heparin treatment of COVID-19 patients Baranca Buijsers, Cansu Yanginlar, Marissa L. Maciej-Hulme, Quirijn de Mast, Johan van der Vlag
83 [GO] 2020―Aug―24 Clinical, immunological and virological characterization of COVID-19 patients that test re-positive for SARS-CoV-2 by RT-PCR Jing Lu, Jinju Peng, Qianling Xiong, Zhe Liu, Huifang Lin, Xiaohua Tan, et al. (+12)
84 [GO] 2020―Aug―20 COVID-19 and vascular disease
85 [GO] 2020―Aug―17 Risk of stroke in hospitalized SARS-CoV-2 infected patients: A multinational study Shima Shahjouei, Soheil Naderi, Jiang Li, Ayesha Khan, Durgesh Chaudhary, Ghasem Farahmand, et al. (+38)
86 [GO] 2020―Aug―17 SARS-CoV2 vertical transmission with adverse effects on the newborn revealed through integrated immunohistochemical, electron microscopy and molecular analyses of Placenta Fabio Facchetti, Mattia Bugatti, Emma Drera, Claudio Tripodo, Enrico Sartori, Valeria Cancila, et al. (+6)
87 [GO] 2020―Aug―15 Immunothrombosis in severe COVID-19 Daigo Nakazawa, Akihiro Ishizu
88 [GO] 2020―Aug―15 Antibody responses in mild COVID-19 hospital staff Mario Plebani
89 [GO] 2020―Aug―15 Early prediction of the risk of severe coronavirus disease 2019: A key step in therapeutic decision making Andréanne Côté, Julien Ternacle, Philippe Pibarot
90 [GO] 2020―Aug―15 Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges Ahmed Abdul Q귮r
91 [GO] 2020―Aug―06 SARS-CoV-2 and ACE2: The biology and clinical data settling the ARB and ACEI controversy Mina K. Chung, Sadashiva Karnik, Joshua Saef, Cornelia Bergmann, John Barnard, Michael M. Lederman, et al. (+14)
92 [GO] 2020―Jul―31 Vascular occlusion by neutrophil extracellular traps in COVID-19 Moritz Leppkes, Jasmin Knopf, Elisabeth Naschberger, Aylin Lindemann, Jeeshan Singh, Irmgard Herrmann, et al. (+17)
93 [GO] 2020―Jul―31 Serologic responses to SARS-CoV-2 infection among hospital staff with mild disease in eastern France Samira Fafi-Kremer, Timothée Bruel, Yoann Madec, Rebecca Grant, Laura Tondeur, Ludivine Grzelak, et al. (+20)
94 [GO] 2020―Jul―29 The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19) Pere Domingo, Isabel Mur, Virginia Pomar, Héctor Corominas, Jordi Casademont, Natividad de Benito
95 [GO] 2020―Jul―24 SARS-CoV-2 detection in different respiratory sites: A systematic review and meta-analysis Abbas Mohammadi, Elmira Esmaeilzadeh, Yijia Li, Ronald J. Bosch, Jonathan Z. Li
96 [GO] 2020―Jul―22 Spatial and temporal dynamics of SARS-CoV-2 in COVID-19 patients: A systematic review and meta-analysis Anne Weiss, Mads Jellingsø, Morten Otto Alexander Sommer
97 [GO] 2020―Jul―22 Linear B-cell epitopes in the spike and nucleocapsid proteins as markers of SARS-CoV-2 exposure and disease severity Siti Naqiah Amrun, Cheryl Yi-Pin Lee, Bernett Lee, Siew-Wai Fong, Barnaby Edward Young, Rhonda Sin-Ling Chee, et al. (+18)
98 [GO] 2020―Jul―21 Lack of antibody-mediated cross-protection between SARS-CoV-2 and SARS-CoV infections Ren Yang, Jiaming Lan, Baoying Huang, Ruhan A, Mingqing Lu, Wen Wang, et al. (+5)
99 [GO] 2020―Jul―07 Reappearance of effector T cells is associated with recovery from COVID-19 Ivan Odak, Joana Barros-Martins, Berislav Bošnjak, Klaus Stahl, Sascha David, Olaf Wiesner, et al. (+13)
100 [GO] 2020―Jul―07 Development and validation of the HNC-LL score for predicting the severity of coronavirus disease 2019 Lu-shan Xiao, Wen-Feng Zhang, Meng-chun Gong, Yan-pei Zhang, Li-ya Chen, Hong-bo Zhu, et al. (+4)
101 [GO] 2020―Jul―03 Illuminating COVID-19 lung disease through autopsy studies David K. Meyerholz, Paul B. McCray
102 [GO] 2020―Jun―21 COVID-19: A time for renewed recognition of science
103 [GO] 2020―Jun―20 Targeting innate immunity by blocking CD14: Novel approach to control inflammation and organ dysfunction in COVID-19 illness Thomas R. Martin, Mark M. Wurfel, Ivan Zanoni, Richard Ulevitch
104 [GO] 2020―Jun―20 Alveolar macrophage dysfunction and cytokine storm in the pathogenesis of two severe COVID-19 patients Chaofu Wang, Jing Xie, Lei Zhao, Xiaochun Fei, Heng Zhang, Yun Tan, et al. (+20)
105 [GO] 2020―Jun―20 Mendelian randomization in COVID-19: Applications for cardiovascular comorbidities and beyond Yaqun Teng, Jiuyang Xu, Yang Zhang, Zhenyu Liu, Shuyang Zhang
106 [GO] 2020―Jun―11 Merits and culprits of immunotherapies for neurological diseases in times of COVID-19 Marc Pawlitzki, Uwe K. Zettl, Tobias Ruck, Leoni Rolfes, Hans-Peter Hartung, Sven G. Meuth
107 [GO] 2020―May―28 Infectivity of human coronavirus in the brain Qi Cheng, Yue Yang, Jianqun Gao
108 [GO] 2020―May―23 COVID-19 as a STING disorder with delayed over-secretion of interferon-beta Jean-Marie Berthelot, Frédéric Lioté
109 [GO] 2020―May―22 Race for a COVID-19 vaccine
110 [GO] 2020―May―07 A glimpse into the eye of the COVID-19 cytokine storm Krutika Kuppalli, Angela L. Rasmussen
111 [GO] 2020―Apr―21 Sedating ventilated COVID-19 patients with inhalational anesthetic drugs Beverley A. Orser, Dian-Shi Wang, Wei-Yang Lu
112 [GO] 2020―Apr―18 Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients Jing Liu, Sumeng Li, Jia Liu, Boyun Liang, Xiaobei Wang, Hua Wang, et al. (+44)
113 [GO] 2020―Apr―16 Impact of immune enhancement on Covid-19 polyclonal hyperimmune globulin therapy and vaccine development Ruklanthi de Alwis, Shiwei Chen, Esther S. Gan, Eng Eong Ooi
114 [GO] 2020―Apr―02 Microneedle array delivered recombinant coronavirus vaccines: Immunogenicity and rapid translational development Eun Kim, Geza Erdos, Shaohua Huang, Thomas W. Kenniston, Stephen C. Balmert, Cara Donahue Carey, et al. (+7)


Last change 2021―Jun―30 20:09:44 UTC

© Daten-Quadrat 2021       Done in 0.006 sec